CRPC w/ Bone Metastases
Doped silica fibre thermoluminescence measurements of radiation dose in the use of (223)Ra
April 28, 2017
Radium-223 inhibits osseous prostate cancer growth by dual targeting of cancer cells and bone microenvironment in mouse models
April 2, 2017
The Role of Therapeutic Layering in Optimizing Treatment for Patients with Castration-Resistant Prostate Cancer (RADAR II)
March 27, 2017
Survival prognosis and variable selection: A case study for metastatic castrate resistant prostate cancer patients
January 25, 2017
Evaluation of bone metastases by 18F-choline PET/CT in a patient with castration-resistant prostate cancer treated with radium-223
December 5, 2016
Radium-223 and metastatic castration-resistant prostate cancer: All that glitters is not gold
November 25, 2016
Radium-223 Therapy of Bone Metastases in Prostate Cancer
November 15, 2016
Prostatic Acid Phosphatase Alters the RANKL/OPG System and Induces Osteoblastic Prostate Cancer Bone Metastases
November 2, 2016
Cancer Cell Colonisation in the Bone Microenvironment
November 2, 2016